Related manufacturer reference 9680001-2015-00039.During a pulmonary vein isolation procedure, a cardiac tamponade occurred.A tacticath quartz ablation catheter was used to perform ablation around all four pulmonary veins.During ablation, a loss of contact force was noted and the catheter was exchanged for a second tacticath quartz ablation catheter, which also lost contact force while difficulty was encountered during catheter manipulation.Another tacticath quartz ablation catheter was used to successfully complete the ablation of the four pulmonary veins.Prior to administering adenosine to verify successfully vein isolation, shadowing around the heart and a reduction in cardiac motion were noted via fluoroscopy.The patient became hypotensive and an echocardiogram revealed a cardiac tamponade.A cardiac perforation was noted on the posterior wall of the left atrium.A pericardiocentesis was performed, which stabilized the patient.
|
(b)(4).One 75 mm tacticath quartz contact force ablation catheter was received for evaluation.The results of the investigation concluded that the catheter displayed acceptable optical signals when connected to the tactisys quartz unit.The device did not meet specifications during a shaft leak test and microscopic inspection of the transition between the catheter shaft and the proximal edge of the distal tip revealed part of the adhesive was no longer adhered, consistent with fluid ingress and a loss of force data during the procedure.As a result of this finding, sjm has made modifications to prevent future occurrences.It is unlikely that this finding contributed to the reported event.The device met specifications prior to leaving sjm manufacturing facilities as supported by a review of the device history record.The cause of the cardiac tamponade remains unknown.Per the ifu, cardiac perforation is a known risk during the use of this device.
|